In summary, our findings demonstrate that the ZEB1/NuRD complex collaboratively suppressed the transcription of the tumor suppressor gene CLDN7, promoted glycolysis, and exerted an impact on tumor development (Figure 6I), potentially signifying the discovery of novel CRC biomarkers. The gene discussed is ZEB1; the disease is neoplasm.